809379603	809379603	CD	B-NP	O
|	|	NN	I-NP	O
TCMRH	TCMRH	NN	I-NP	O
|	|	NN	I-NP	O
04791966	04791966	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5101293	5101293	CD	B-NP	O
|	|	CC	I-NP	O
3/26/2005	3/26/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CORONARY	CORONARY	NNP	I-NP	I-protein
ARTERY	ARTERY	NNP	I-NP	I-protein
DISEASE	DISEASE	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/3/2005	7/3/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/13/2005	11/13/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
MCKENZIE	MCKENZIE	NNP	B-NP	O
,	,	,	O	O
WILLY	WILLY	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
78-year-old	78-year-old	JJ	I-NP	O
gentleman	gentleman	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
non-insulin-dependent	non-insulin-dependent	JJ	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
and	and	CC	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
who	who	WP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
two	two	CD	B-NP	O
prior	prior	JJ	I-NP	O
MIs	MI	NNS	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
diabetes	diabetes	NN	B-NP	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
to	to	TO	B-PP	O
an	an	DT	B-NP	O
outside	outside	JJ	I-NP	O
hospital	hospital	NN	I-NP	O
on	on	IN	B-PP	O
9/4/05	9/4/05	CD	B-NP	O
with	with	IN	B-PP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
cough	cough	NN	B-NP	O
,	,	,	O	O
minimal	minimal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
left-sided	left-sided	JJ	B-NP	O
arm	arm	NN	I-NP	O
uneasiness	uneasiness	NN	I-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
single	single	JJ	I-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
vomiting	vomit	VBG	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
symptoms	symptom	NNS	I-NP	O
were	be	VBD	B-VP	O
relieved	relieve	VBN	I-VP	O
with	with	IN	B-PP	O
sublingual	sublingual	JJ	B-NP	O
nitroglycerin	nitroglycerin	NN	I-NP	O
and	and	CC	I-NP	O
Lasix	Lasix	NN	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
mildly	mildly	RB	B-ADJP	O
elevated	elevated	JJ	I-ADJP	O
.	.	.	O	O

An	An	DT	B-NP	O
echocardiogram	echocardiogram	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
which	which	WDT	B-NP	O
estimated	estimate	VBD	B-VP	O
his	his	PRP$	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
-25	-25	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
noted	note	VBD	B-VP	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
mitral	mitral	JJ	B-NP	O
regurgitation	regurgitation	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
left-to-right	left-to-right	JJ	I-NP	O
shunt	shunt	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
on	on	IN	B-PP	O
4/10/05	4/10/05	CD	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
triple	triple	JJ	B-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Tin	Tin	NNP	B-NP	B-protein
Rogers	Rogers	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
on	on	IN	B-PP	O
4/10/05	4/10/05	CD	B-NP	O
for	for	IN	B-PP	O
surgical	surgical	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
MI	MI	NN	I-NP	O
x2	x2	NN	I-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
peripheral	peripheral	JJ	B-NP	O
vascular	vascular	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
on	on	IN	B-PP	O
oral	oral	JJ	B-NP	O
agent	agent	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
COPD	COPD	NN	B-NP	O
on	on	IN	B-PP	O
bronchodilators	bronchodilator	NNS	B-NP	O
,	,	,	O	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
peptic	peptic	JJ	B-NP	O
ulcer	ulcer	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
GERD	GERD	NN	B-NP	O
.	.	.	O	O

PAST	PAST	NN	B-NP	O
SURGICAL	SURGICAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Includes	Include	VBZ	B-VP	O
a	a	DT	B-NP	O
left	left	JJ	I-NP	O
carotid	carotid	NN	I-NP	O
endarterectomy	endarterectomy	NN	I-NP	O
done	do	VBN	B-VP	O
in	in	IN	B-PP	O
1997	1997	CD	B-NP	O
and	and	CC	O	O
TURP	TURP	NN	B-NP	B-protein
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Positive	Positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
smoking	smoking	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Aspirin	Aspirin	NN	B-NP	O
causing	cause	VBG	B-VP	O
gastritis	gastritis	NN	B-NP	O
,	,	,	O	O
Keflex	Keflex	NNP	B-NP	O
causing	cause	VBG	I-NP	O
hives	hive	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Bactrim	Bactrim	NNP	B-NP	O
causing	cause	VBG	I-NP	O
hives	hive	NNS	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Include	Include	NNP	B-NP	O
Toprol	Toprol	NNP	I-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
fosinopril	fosinopril	VBP	B-VP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.125	0.125	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
,	,	,	O	O
ipratropium	ipratropium	NN	B-NP	O
two	two	CD	I-NP	O
puff	puff	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
atorvastatin	atorvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
glyburide	glyburide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Avandia	Avandia	NNP	B-NP	O
8	8	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
also	also	RB	B-ADVP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
at	at	IN	B-PP	O
500	500	CD	B-NP	B-DNA
units	unit	NNS	I-NP	I-DNA
an	an	DT	B-NP	O
hour	hour	NN	I-NP	O
on	on	IN	B-PP	O
transfer	transfer	NN	B-NP	O
from	from	IN	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
5	5	CD	B-NP	O
feet	foot	NNS	I-NP	O
5	5	CD	B-NP	O
inches	inch	NNS	I-NP	O
tall	tall	JJ	B-ADJP	O
,	,	,	O	O
75	75	CD	B-NP	O
kilos	kilo	NNS	I-NP	O
,	,	,	O	O
temperature	temperature	NN	B-NP	B-protein
98.2	98.2	CD	I-NP	I-protein
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
60	60	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
110/60	110/60	CD	I-NP	O
in	in	IN	B-PP	O
right	right	JJ	B-NP	O
arm	arm	NN	I-NP	O
,	,	,	O	O
106/54	106/54	CD	B-NP	O
in	in	IN	B-PP	O
left	left	JJ	B-NP	O
arm	arm	NN	I-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
PERRL	PERRL	NN	B-NP	B-protein
.	.	.	O	O

Oropharynx	Oropharynx	NN	B-NP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
upper	upper	JJ	B-NP	O
dentures	denture	NNS	I-NP	O
the	the	DT	B-NP	O
lower	low	JJR	I-NP	O
teeth	tooth	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
no	no	DT	B-NP	O
carotid	carotid	NN	I-NP	O
bruits	bruit	NNS	I-NP	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
his	his	PRP$	B-NP	O
radiates	radiate	NNS	I-NP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
carotids	carotid	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
well-healed	well-healed	JJ	I-NP	O
incision	incision	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
left	left	JJ	I-NP	O
neck	neck	NN	I-NP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
:	:	:	O	O
Without	Without	IN	B-PP	O
incisions	incision	NNS	B-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
3/6	3/6	CD	B-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-ADJP	O
:	:	:	O	O
Breath	Breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
are	be	VBP	B-VP	O
clear	clear	JJ	B-ADJP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
incisions	incision	NNS	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
mild	mild	JJ	B-NP	O
ecchymosis	ecchymosis	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Mild	Mild	NNP	B-NP	O
ankle	ankle	NN	I-NP	O
edema	edema	NN	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
mild	mild	JJ	B-NP	O
brown	brown	JJ	I-NP	O
discoloration	discoloration	NN	I-NP	O
and	and	CC	O	O
left	leave	VBD	B-VP	O
lower	low	JJR	B-NP	O
leg	leg	NN	I-NP	O
and	and	CC	I-NP	O
ankle	ankle	NN	I-NP	O
,	,	,	O	O
bilateral	bilateral	JJ	B-NP	O
lower	low	JJR	I-NP	O
leg	leg	NN	I-NP	O
varicosities	varicosity	NNS	I-NP	O
,	,	,	O	O
mild	mild	JJ	B-ADJP	O
on	on	IN	B-PP	O
right	right	JJ	B-ADJP	O
,	,	,	O	O
more	more	RBR	B-ADJP	O
prominent	prominent	JJ	I-ADJP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pedal	pedal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
radial	radial	NN	I-NP	O
pulses	pulse	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Allen	Allen	NNP	B-NP	O
's	's	POS	B-NP	O
test	test	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
is	be	VBZ	B-VP	O
normal	normal	JJ	B-ADJP	O
by	by	IN	B-PP	O
pulse	pulse	NN	B-NP	O
oximeter	oximeter	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
extremity	extremity	NN	I-NP	O
is	be	VBZ	B-VP	O
abnormal	abnormal	JJ	B-ADJP	O
by	by	IN	B-PP	O
pulse	pulse	NN	B-NP	O
oximeter	oximeter	NN	I-NP	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
:	:	:	O	O
Alert	Alert	NNP	B-NP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
,	,	,	O	O
grossly	grossly	RB	B-NP	O
nonfocal	nonfocal	JJ	I-NP	O
exam	exam	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
hard	hard	JJ	B-ADJP	O
of	of	IN	B-PP	O
hearing	hearing	NN	B-NP	O
and	and	CC	O	O
uses	use	VBZ	B-VP	O
a	a	DT	B-NP	O
hearing	hearing	NN	I-NP	O
aid	aid	NN	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
Preoperative	Preoperative	JJ	B-NP	O
chemistries	chemistry	NNS	I-NP	O
include	include	VBP	B-VP	O
sodium	sodium	NN	B-NP	O
of	of	IN	B-PP	O
138	138	CD	B-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
5	5	CD	B-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	O
of	of	IN	B-PP	O
24	24	CD	B-NP	O
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
glucose	glucose	NN	B-NP	O
is	be	VBZ	B-VP	O
176	176	CD	B-NP	O
.	.	.	O	O

Glycosylated	Glycosylate	VBN	B-NP	B-protein
hemoglobin	hemoglobin	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
5.9	5.9	CD	B-NP	O
.	.	.	O	O

White	White	JJ	B-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
is	be	VBZ	B-VP	O
6.4	6.4	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
39	39	CD	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
1.1	1.1	CD	B-NP	O
.	.	.	O	O

PTT	PTT	NN	B-NP	O
is	be	VBZ	B-VP	O
52	52	CD	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
data	datum	NNS	I-NP	O
from	from	IN	B-PP	O
4/10/05	4/10/05	CD	B-NP	O
performed	perform	VBN	B-VP	O
at	at	IN	B-PP	O
outside	outside	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
includes	include	VBZ	B-VP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	NN	I-NP	O
left	leave	VBD	B-VP	O
main	main	JJ	B-ADJP	O
,	,	,	O	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
proximal	proximal	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
mid	mid	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
right	right	JJ	I-NP	O
dominant	dominant	JJ	I-NP	O
circulation	circulation	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
moderate	moderate	JJ	B-NP	O
disease	disease	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
origin	origin	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
diagonal	diagonal	JJ	I-NP	O
branch	branch	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
circumflex	circumflex	NN	I-NP	O
is	be	VBZ	B-VP	O
totally	totally	RB	I-VP	O
occluded	occlude	VBN	I-VP	O
proximally	proximally	RB	B-ADVP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
there	there	EX	B-NP	O
antegrade	antegrade	JJ	B-NP	O
collaterals	collateral	NNS	I-NP	O
which	which	WDT	B-NP	O
opacify	opacify	VBP	B-VP	O
a	a	DT	B-NP	O
large	large	JJ	I-NP	O
part	part	NN	I-NP	O
bifurcating	bifurcate	VBG	B-VP	O
obtuse	obtuse	NN	B-NP	O
marginal	marginal	JJ	I-NP	O
branch	branch	NN	I-NP	O
.	.	.	O	O

RCA	RCA	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
occluded	occlude	VBN	I-VP	O
,	,	,	O	O
antegrade	antegrade	VB	B-VP	O
collaterals	collateral	NNS	B-NP	O
to	to	TO	B-PP	O
acute	acute	JJ	B-NP	O
marginal	marginal	JJ	I-NP	O
,	,	,	I-NP	O
distal	distal	JJ	I-NP	O
RCA	RCA	NN	I-NP	O
and	and	CC	I-NP	O
PDA	PDA	NN	I-NP	B-protein
collateralized	collateralize	VBD	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circulation	circulation	NN	I-NP	O
.	.	.	O	O

LIMA	LIMA	NN	B-NP	B-protein
is	be	VBZ	B-VP	O
widely	widely	RB	B-ADJP	O
patent	patent	JJ	I-ADJP	O
.	.	.	O	O

Ventriculogram	Ventriculogram	NNP	B-NP	O
notes	note	VBZ	B-VP	O
inferobasal	inferobasal	JJ	B-NP	O
akinesis	akinesis	NN	I-NP	O
,	,	,	O	O
apical	apical	JJ	B-NP	O
akinesis	akinesis	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
anterior	anterior	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
1-2	1-2	NN	B-NP	O
+	+	SYM	O	O
MR.	MR.	NNP	B-NP	O
Hemodynamics	Hemodynamics	NNP	I-NP	O
PCW	PCW	NNP	I-NP	O
is	be	VBZ	B-VP	O
10	10	CD	B-NP	O
and	and	CC	I-NP	O
cardiac	cardiac	JJ	I-NP	O
index	index	NN	I-NP	O
is	be	VBZ	B-VP	O
2.1	2.1	CD	B-NP	O
.	.	.	O	O

Echocardiogram	Echocardiogram	NN	B-NP	O
from	from	IN	B-PP	O
9/4/05	9/4/05	CD	B-NP	O
estimates	estimate	NNS	I-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
at	at	IN	B-PP	O
20	20	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
notes	note	VBZ	B-VP	O
aortic	aortic	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
mean	mean	JJ	I-NP	O
gradient	gradient	NN	I-NP	O
of	of	IN	B-PP	O
17	17	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
peak	peak	JJ	I-NP	O
gradient	gradient	NN	I-NP	O
of	of	IN	B-PP	O
32	32	CD	B-NP	O
mmHg	mmHg	NN	I-NP	O
,	,	,	O	O
calculated	calculate	VBN	B-VP	O
valve	valve	VBP	B-VP	O
area	area	NN	B-NP	O
of	of	IN	B-PP	O
1	1	CD	B-NP	O
cm2	cm2	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
trivial	trivial	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
mitral	mitral	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
trivial	trivial	JJ	B-NP	O
pulmonic	pulmonic	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
diffuse	diffuse	JJ	B-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
most	most	RBS	B-VP	O
notably	notably	RB	I-VP	O
involving	involve	VBG	I-VP	O
the	the	DT	B-NP	O
inferoposterior	inferoposterior	JJ	I-NP	O
and	and	CC	I-NP	O
anteroseptal	anteroseptal	JJ	I-NP	O
walls	wall	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
dilated	dilated	JJ	I-NP	O
left	left	JJ	I-NP	O
atrium	atrium	NN	I-NP	O
,	,	,	O	O
CVP	CVP	NN	B-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
,	,	,	O	O
small	small	JJ	B-NP	O
left-to-right	left-to-right	JJ	I-NP	O
shunt	shunt	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
ostium	ostium	NN	B-NP	O
secundum	secundum	NN	I-NP	O
ASD	ASD	NN	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
normal	normal	JJ	I-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
at	at	IN	B-PP	O
80	80	CD	B-NP	O
,	,	,	O	O
left	leave	VBD	B-VP	O
bundle-branch	bundle-branch	NN	B-NP	O
block	block	NN	I-NP	O
with	with	IN	B-PP	O
inverted	invert	VBN	B-NP	O
Ts	T	NNS	I-NP	O
in	in	IN	B-PP	O
I	I	NN	B-NP	O
,	,	,	I-NP	O
aVL	aVL	NN	I-NP	O
,	,	,	I-NP	O
V5	V5	NN	I-NP	B-protein
and	and	CC	I-NP	O
V6	V6	NN	I-NP	B-protein
,	,	,	O	O
sinus	sinus	NN	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
first-degree	first-degree	JJ	I-NP	O
block	block	NN	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
is	be	VBZ	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
1/1/05	1/1/05	CD	B-NP	O
and	and	CC	O	O
underwent	undergo	VBD	B-VP	O
aortic	aortic	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
23	23	CD	I-NP	O
mm	mm	NN	I-NP	O
Carpentier-Edwards	Carpentier-Edwards	NNP	I-NP	O
Magna	Magna	NNP	I-NP	O
valve	valve	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
CABG	CABG	NN	B-NP	B-protein
x4	x4	NN	I-NP	I-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
sequential	sequential	JJ	I-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
connecting	connect	VBG	B-VP	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
to	to	TO	B-PP	O
D1	D1	NN	B-NP	O
and	and	CC	B-NP	O
then	then	RB	I-NP	O
OM1	OM1	NN	B-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
graft	graft	NN	I-NP	O
,	,	,	O	O
LIMA	LIMA	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	O	O
another	another	DT	B-NP	O
vein	vein	NN	I-NP	O
graft	graft	NN	I-NP	O
connecting	connect	VBG	B-VP	O
the	the	DT	B-NP	O
aorta	aorta	NN	I-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
PDA	PDA	NN	I-NP	B-protein
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
underwent	undergo	VBD	B-VP	O
a	a	DT	B-NP	O
PFO	PFO	NNP	I-NP	O
closure	closure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Intensive	Intensive	JJ	I-NP	O
Care	Care	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
following	follow	VBG	B-PP	O
surgery	surgery	NN	B-NP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
26	26	CD	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
guaiac	guaiac	JJ	B-ADJP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Step-Down	Step-Down	NNP	I-NP	O
Unit	Unit	NNP	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

SUMMARY	SUMMARY	NN	B-NP	O
BY	BY	NN	I-NP	O
SYSTEM	SYSTEM	NN	I-NP	O
AS	AS	NN	I-NP	O
FOLLOW	FOLLOW	NN	I-NP	O
:	:	:	O	O
Neurologically	Neurologically	RB	B-ADVP	O
:	:	:	O	O
No	No	DT	B-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
pain	pain	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
his	his	PRP$	B-NP	O
Cardiology	Cardiology	NN	I-NP	O
perioperatively	perioperatively	RB	B-ADVP	O
.	.	.	O	O

Respiratory	Respiratory	NNP	B-NP	O
:	:	:	O	O
Blake	Blake	VB	B-VP	O
drain	drain	NN	B-NP	O
discontinued	discontinue	VBN	B-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Post-pull	Post-pull	JJ	B-NP	O
chest	chest	NN	I-NP	O
x-ray	x-ray	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
No	No	DT	B-NP	O
issues	issue	NNS	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
good	good	JJ	I-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
to	to	TO	B-VP	O
support	support	VB	I-VP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
issues	issue	NNS	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Diabetes	Diabetes	NNP	I-NP	O
Management	Management	NNP	I-NP	O
Service	Service	NNP	I-NP	O
perioperatively	perioperatively	RB	B-ADVP	O
for	for	IN	B-PP	O
hyperglycemia	hyperglycemia	NN	B-NP	O
.	.	.	O	O

Hematology	Hematology	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
3	3	CD	I-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
Plavix	Plavix	NN	B-NP	O
as	as	IN	B-SBAR	O
patient	patient	NN	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
aspirin	aspirin	NN	I-NP	O
allergy	allergy	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
4	4	CD	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
oxygen	oxygen	NN	B-NP	O
and	and	CC	O	O
saturated	saturate	VBN	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
maintained	maintain	VBD	B-VP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
duration	duration	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
began	begin	VBD	B-VP	O
ambulating	ambulate	VBG	I-VP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
unsteady	unsteady	JJ	B-ADJP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
feet	foot	NNS	I-NP	O
and	and	CC	O	O
walks	walk	VBZ	B-VP	O
with	with	IN	B-PP	O
assistance	assistance	NN	B-NP	O
,	,	,	O	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
rehabilitation	rehabilitation	NN	B-NP	O
screening	screening	NN	I-NP	O
.	.	.	O	O

Later	Later	RB	B-ADVP	O
that	that	DT	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
noted	note	VBD	B-VP	O
visual	visual	JJ	B-NP	O
disturbances	disturbance	NNS	I-NP	O
which	which	WDT	B-NP	O
included	include	VBD	B-VP	O
blurriness	blurriness	NN	B-NP	O
and	and	CC	I-NP	O
wavy	wavy	NN	I-NP	O
vision	vision	NN	I-NP	O
that	that	WDT	B-NP	O
lasted	last	VBD	B-VP	O
two	two	CD	B-NP	O
and	and	CC	I-NP	O
a	a	DT	I-NP	O
half	half	NN	I-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
CT	CT	NN	I-NP	O
angio	angio	NN	I-NP	O
scan	scan	NN	I-NP	O
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
negative	negative	JJ	B-ADJP	O
for	for	IN	B-PP	O
acute	acute	JJ	B-NP	O
pathology	pathology	NN	I-NP	O
.	.	.	O	O

Neurology	Neurology	NN	B-NP	O
team	team	NN	I-NP	O
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
and	and	CC	O	O
a	a	DT	B-NP	O
stat	stat	NN	I-NP	O
CT	CT	NN	I-NP	O
angio	angio	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
head	head	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

This	This	DT	B-NP	O
study	study	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
no	no	DT	B-NP	O
high-grade	high-grade	JJ	I-NP	O
stenoses	stenosis	NNS	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
recommended	recommend	VBN	I-VP	O
that	that	IN	B-SBAR	O
an	an	DT	B-NP	O
ophthalmology	ophthalmology	NN	I-NP	O
consult	consult	NN	I-NP	O
be	be	VB	B-VP	O
obtained	obtain	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
ophthalmologist	ophthalmologist	NN	I-NP	O
examined	examine	VBD	B-VP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
found	find	VBD	B-VP	O
no	no	DT	B-NP	O
indication	indication	NN	I-NP	O
of	of	IN	B-PP	O
pathology	pathology	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
visual	visual	JJ	I-NP	O
disturbances	disturbance	NNS	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
brief	brief	JJ	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
rate	rate	NN	B-NP	O
controlled	controlled	JJ	I-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
#	#	#	B-NP	O
6	6	CD	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
converted	convert	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	B-DNA
increased	increase	VBN	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
sinus	sinus	NN	B-NP	O
rhythm	rhythm	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
remainder	remainder	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
postoperative	postoperative	JJ	I-NP	O
stay	stay	NN	I-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
work	work	VB	I-VP	O
with	with	IN	B-PP	O
physical	physical	JJ	B-NP	O
therapy	therapy	NN	I-NP	O
and	and	CC	O	O
improved	improve	VBN	B-VP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
waited	wait	VBD	B-VP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
available	available	JJ	I-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
bed	bed	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
in	in	IN	B-PP	O
good	good	JJ	B-NP	O
condition	condition	NN	I-NP	O
on	on	IN	B-PP	O
postoperative	postoperative	JJ	B-NP	O
day	day	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Discharged	Discharge	VBN	B-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
following	follow	VBG	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
650	650	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
constipation	constipation	NN	I-NP	O
,	,	,	O	O
Lasix	Lasix	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
slow	slow	JJ	I-NP	O
release	release	NN	I-NP	O
10	10	CD	I-NP	O
mEq	mEq	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
glipizide	glipizide	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
ibuprofen	ibuprofen	NN	B-NP	O
600	600	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
2.5	2.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
two	two	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaled	inhale	VBD	B-VP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Glucophage-XR	Glucophage-XR	NN	B-NP	O
500	500	CD	I-NP	O
mg	mg	NN	I-NP	O
following	follow	VBG	B-PP	O
breakfast	breakfast	NN	B-NP	O
and	and	CC	I-NP	O
Glucophage-XR	Glucophage-XR	NN	I-NP	B-protein
500	500	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
following	follow	VBG	B-PP	I-protein
supper	supper	NN	B-NP	I-protein
,	,	,	O	O
Zetia	Zetia	NNP	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Protonix	Protonix	NNP	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
atorvastatin	atorvastatin	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Toprol-XL	Toprol-XL	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

FOLLOW-UP	FOLLOW-UP	JJ	B-NP	O
APPOINTMENTS	APPOINTMENTS	NNS	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
follow-up	follow-up	JJ	B-NP	O
appointments	appointment	NNS	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Rouff	Rouff	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
to	to	TO	B-PP	O
two	two	CD	B-NP	O
weeks	week	NNS	I-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
surgeon	surgeon	NN	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Ollom	Ollom	NNP	I-NP	O
,	,	,	O	O
in	in	IN	B-PP	O
four	four	CD	B-NP	O
to	to	TO	I-NP	O
six	six	CD	I-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
0-8435267	0-8435267	CD	B-NP	O
EMS	EMS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
DRYER	DRYER	NNP	B-NP	O
,	,	,	O	O
JAY	JAY	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SLUKA	SLUKA	NN	B-NP	B-protein
,	,	,	O	O
SAUL	SAUL	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5099255	5099255	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
10/8/05	10/8/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
10/8/05	10/8/05	CD	B-NP	O

